News & Resources

Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.

  • Lower Attrition Rates = Trials Completed Sooner 

    Clinical trials fall behind schedule long before deadlines are missed.  Attrition builds gradually as patients encounter repeated barriers to participation. In traditional trial models, those barriers are often logistical- travel distance, time away from work or family, and the burden of returning to unfamiliar sites over the course of a study. Community-based clinical trials […]

  • From Data Collection to Decision-Making in Clinical Trials

    Clinical trials are generating unprecedented volumes of data, yet translating that data into timely, confident decisions remains a persistent challenge. This executive summary captures insights from the 2026 SCOPE Roundtable featuring experts from Biogen, Veristat, Endeavor BioMedicines, Contraline, and EmVenio Clinical Research. Together, they explore how protocol design, real-time visibility, […]

  • Showing Up Where It Matters: Juneteenth ATL 2026

    The Juneteenth ATL Parade & Music Festival is a vibrant, three-day celebration of freedom, culture, and community held in the heart of Atlanta. This year, our team partnered with Sanofi to engage directly with attendees and expand awareness of clinical research through approachable, in-person conversations.  Gaps in clinical trial representation persist, […]

  • Increased Reach & Awareness = Faster Enrollment

    The biggest barrier to enrollment isn’t eligibility, it’s access.  Most clinical trials don’t struggle because patients don’t exist- they struggle because patients can’t easily participate. Traditional site models often require patients to travel significant distances, reducing access and constraining enrollment from the start.  Community-based clinical trials change that dynamic by expanding where trials take place. Instead of asking patients to come to the […]

  • The Triple Effect of Community-Based Clinical Trials

    Community-based clinical trials are no longer a future concept—they’re an underutilized advantage. As decentralized clinical trials (DCTs) and site networks continue to gain momentum, “community based trials” are increasingly part of the conversation. Yet despite the attention, many sponsors still hesitate to adopt them at scale. So what’s holding them […]

  • Honoring Cancer Survivors: This Month and Always 

    Honoring Cancer Survivors: This Month and Always 

    Every June, National Cancer Survivor Month invites us to celebrate resilience, honor survivorship, and recognize the ongoing needs of millions of people living with and beyond cancer. Today, more than 18 million individuals in the United States are navigating life after diagnosis—each with a unique journey shaped by treatment, recovery, and long-term […]

  • Redesigning Reach: Community-Based Research In Action – Part 3

    As our series on community‑based research continues, one thing is clear: the industry is aligned on the promise – but still working through execution. In partnership with Citeline, we surveyed 130 leaders from biotech companies, pharmaceutical organizations and CROs to understand how community‑centric models are being evaluated in practice. In […]

  • Inclusive Research Starts Locally: Improving Trial Readiness Through Community‑Based Models

    Clinical research is evolving, driven by a growing recognition that meaningful community engagement is essential for equitable, efficient trials and strong study outcomes. Today’s leading organizations are shifting from transactional site activation models to relationship‑based approaches rooted in trust, representation and deep local presence. This webinar explores how inclusive research can be […]

  • Professional Case Management and EmVenio Clinical Research poised for transformation with expansion of executive leadership team

    DENVER, Colo., April 15, 2026 – Professional Case Management (PCM) and its clinical research division, EmVenio Clinical Research, today announced the appointment of new executive leaders. Beth Perez joins as chief of staff, and Sarah Zwicky was named chief marketing officer effective immediately. Both will join the executive team reporting to Greg […]

  • EmVenio attends World Vaccine Congress 2026

    Last week, the EmVenio team traveled to Washington, D.C., for the 2026 World Vaccine Congress. The week was full of thoughtful conversations, new connections, and meaningful discussions about where vaccine research is headed – and how we can continue improving how trials are designed and delivered.  Throughout the conference, we connected with sponsors, partners, […]

  • Building Trust Through Connection: EmVenio at the Atlanta Black Expo 

    At the end of February, our team had the privilege of participating at the Atlanta Black Expo – a vibrant celebration of Black entrepreneurship, community leadership, and wellness. For EmVenio, it was more than an event. It was an opportunity to build meaningful, long-term relationships with the communities we serve. Strengthening Community Partnerships One of the strongest takeaways from the […]

  • How Community-Based Trials Are Delivering Results: Investigator and Site Perspectives

    Clinical research succeeds when protocols prioritize the patient experience. Community‑based trials continue to demonstrate that bringing research closer to participants reduces barriers, improves access, and creates opportunities for more inclusive engagement. In this webinar, speakers from EmVenio share real‑world data and experiences illustrating how community‑based models deliver measurable results. The […]